Filter posts

BIO Chimes In: TC Heartland LLC v. Kraft Food Brands Group LLC (Supreme Court)

This is part two of a three part series on BIO’s recently submitted amicus briefs in cases …

Four Former FDA Commissioners Warn About Drug Importation Dangers

Last week, four former FDA Commissioners – Robert M. Califf, Margaret B. Hamburg, Mark B. …

ICYMI: The Hill Op-Ed on Ending 340B Abuse

Writing in The Hill today, Ellen Weaver of the Palmetto Promise Institute and Lindsay Boyd …

BIO on CNBC: IPR System Weakens Medical Innovation

Last night Ron Cohen, M.D., CEO of Acorda Therapeutics and BIO’s board chair, appeared on …

Here are the Facts about the IPR Kill Rate

FiercePhrma recently ran an article repeating a dubious analysis of the crisis caused by the …

Reflecting on July 2015: “The Ag Biotech Debate Was Front and Center”

Agri-Pulse recently published an op-ed titled “The Biotechnology Riddle” by Marshall Matz which outlined how …

Seventy Nine House Members Express Concern with H.R. 9

House leaders made the decision earlier this month to remove patent reform legislation from the …

Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?

In 2009, Congress passed the Biologics Price Competition and Innovation Act (“BPCIA”), which for the first …

BIO Coalition Submits Patent Reform Letter to Congress

BIO, alongside a coalition of patent holders and inventors, submitte